According to SEC filings for the period ending December 2025, Inmune Bio, Inc. (NASDAQ:INMB) is held by 68 institutional firms.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 1,212,100 | 25,224 | 2.13% | $1,890,877.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 957,846 | 81,554 | 9.31% | $1,494,240.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 441,650 | -27,790 | -5.92% | $689,170.00 |
| STATE STREET CORP | 31 Dec, 2025 | 347,259 | 63,426 | 22.35% | $541,724.00 |
| Dauntless Investment Group, LLC | 31 Dec, 2025 | 304,922 | 304,922 | 0.00% | $475,678.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Dec, 2025 | 250,910 | 93,956 | 59.86% | $391,419.00 |
| NORTHERN TRUST CORP | 31 Dec, 2025 | 175,649 | -13,467 | -7.12% | $274,012.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 122,512 | 46,802 | 61.82% | $191,120.00 |
| Westside Investment Management, Inc. | 31 Dec, 2025 | 108,950 | 5,500 | 5.32% | $169,962.00 |
| XTX Topco Ltd | 31 Dec, 2025 | 68,865 | 68,865 | 0.00% | $107,429.00 |
| UBS Group AG | 31 Dec, 2025 | 60,803 | -94,719 | -60.90% | $94,852.00 |
| Bank of New York Mellon Corp | 31 Dec, 2025 | 58,521 | -1,330 | -2.22% | $91,293.00 |
| GOLDMAN SACHS GROUP INC | 31 Dec, 2025 | 56,477 | 41,173 | 269.03% | $88,104.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Dec, 2025 | 50,252 | 8,427 | 20.15% | $78,393.00 |
| Laird Norton Wetherby Trust Company, LLC | 31 Dec, 2025 | 45,000 | 20,000 | 80.00% | $70,200.00 |
| Jain Global LLC | 31 Dec, 2025 | 42,051 | 42,051 | 0.00% | $65,600.00 |
| JPMORGAN CHASE & CO | 31 Dec, 2025 | 41,365 | -16,349 | -28.33% | $64,530.00 |
| Focus Partners Advisor Solutions, LLC | 31 Dec, 2025 | 41,097 | 147 | 0.36% | $64,111.00 |
| PNC FINANCIAL SERVICES GROUP, INC. | 31 Dec, 2025 | 37,805 | -582 | -1.52% | $58,976.00 |
| BARCLAYS PLC | 31 Dec, 2025 | 32,018 | 2,012 | 6.71% | $49,949.00 |